JP2000140067A - Hermetically sealed hollow container, and its manufacture - Google Patents

Hermetically sealed hollow container, and its manufacture

Info

Publication number
JP2000140067A
JP2000140067A JP10261031A JP26103198A JP2000140067A JP 2000140067 A JP2000140067 A JP 2000140067A JP 10261031 A JP10261031 A JP 10261031A JP 26103198 A JP26103198 A JP 26103198A JP 2000140067 A JP2000140067 A JP 2000140067A
Authority
JP
Japan
Prior art keywords
container
sealed hollow
hollow container
chemical solution
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10261031A
Other languages
Japanese (ja)
Inventor
Seigo Ishioka
岡 征 悟 石
Kazuo Minase
和 夫 水無瀬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Valqua Industries Ltd
Nihon Valqua Kogyo KK
Original Assignee
Nippon Valqua Industries Ltd
Nihon Valqua Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Valqua Industries Ltd, Nihon Valqua Kogyo KK filed Critical Nippon Valqua Industries Ltd
Priority to JP10261031A priority Critical patent/JP2000140067A/en
Publication of JP2000140067A publication Critical patent/JP2000140067A/en
Pending legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C66/00General aspects of processes or apparatus for joining preformed parts
    • B29C66/70General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material
    • B29C66/71General aspects of processes or apparatus for joining preformed parts characterised by the composition, physical properties or the structure of the material of the parts to be joined; Joining with non-plastics material characterised by the composition of the plastics material of the parts to be joined
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C65/00Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
    • B29C65/02Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor by heating, with or without pressure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2027/00Use of polyvinylhalogenides or derivatives thereof as moulding material
    • B29K2027/12Use of polyvinylhalogenides or derivatives thereof as moulding material containing fluorine
    • B29K2027/18PTFE, i.e. polytetrafluorethene, e.g. ePTFE, i.e. expanded polytetrafluorethene

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Blow-Moulding Or Thermoforming Of Plastics Or The Like (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a hermetically sealed hollow container wherein the carrying over of a chemical is eliminated, the cleaning property is excellent, and the strength is high, and which is suitable for the storage of a high purity chemical by forming a container main body and a lid body which is fitted on the opening of the main body of a specified modified polytetrafluoroethylene which cannot be worked from a molten state. SOLUTION: This hermetically sealed hollow container 10 for chemical storage is constituted of a container main body 11 wherein a chemical storage section 11a is formed by cutting the internal surface, and a lid body 12 which is fitted on the opening 11b of the container main body 11. In this case, the container main body 11 and the lid body 12 are respectively formed of modified polytetrafluoroethylene which cannot be worked from a molten state. The modified polytetrafluoroethylene is a copolymer at least containing 0.001-1 wt.% of a component unit which is derived from perfluorovinyl ether represented by the formula: CF2=CF-O-X, and a component unit which is derived from tetrafluoroethylene. Then, the container main body 11 and the lid body 12 are integrated by re-sintering together with fusing.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、半導体用ウェハ
や、液晶用基板などを処理するプロセスにおいて使用さ
れる各種の高純度薬液の貯蔵や、医療用として殺菌洗浄
に用いられるオゾン水製造装置における薬液を貯蔵する
のに好適な密封中空容器およびその製造方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an ozone water producing apparatus used for storing various kinds of high-purity chemicals used in processes for processing semiconductor wafers, liquid crystal substrates, and the like, and for sterilization cleaning for medical use. The present invention relates to a sealed hollow container suitable for storing a chemical solution and a method for producing the same.

【0002】[0002]

【従来の技術】フッ素樹脂は、耐薬品性、耐熱性、純粋
性に優れていることから、半導体製造プロセスや医療等
に使用される高純度薬液貯蔵容器の素材として使用され
る。フッ素樹脂には、溶融成形ができず、原料粉末を押
し固めて予備成形体とし、この予備成形体を、融点以上
に加熱焼成して成形されるPTFE(ポリテトラフルオ
ロエチレン)と、溶融成形可能なPFA(ポリテトラフ
ルオロエチレン/パーフルオロアルキルビニルエーテル
共重合体)、FEP(テトラフルオロエチレン/ヘキサ
フルオロプロピレン共重合体)、ETFE(エチレン/
テトラフルオロエチレン共重合体)、PVDE(ポリフ
ッ化ビニリデン)などに大別される。
2. Description of the Related Art Fluororesins have excellent chemical resistance, heat resistance and purity, and are therefore used as materials for high-purity chemical liquid storage containers used in semiconductor manufacturing processes and medical treatments. Fluorine resin cannot be melt-molded, and the raw material powder is compacted to form a preform, and this preform can be melt-molded with PTFE (polytetrafluoroethylene), which is formed by heating and firing at a temperature above the melting point. PFA (polytetrafluoroethylene / perfluoroalkyl vinyl ether copolymer), FEP (tetrafluoroethylene / hexafluoropropylene copolymer), ETFE (ethylene /
(Tetrafluoroethylene copolymer), PVDE (polyvinylidene fluoride) and the like.

【0003】このようなフッ素樹脂において、生産性の
面では、押出成形、射出成形が可能な溶融樹脂(PF
A、FEP等)が有利であるが、上記特性の面では、P
TFEにおよばないため、今なおPTFE製の容器に対
する要求が高い。
[0003] In such a fluororesin, in terms of productivity, a molten resin (PF) which can be extruded and injection-molded.
A, FEP, etc.) are advantageous, but in terms of the above characteristics, P
Since it does not reach TFE, there is still a high demand for a container made of PTFE.

【0004】しかしながら、PTFEは、上記のように
射出成形等ができないため、密封中空容器を一体成形す
ることができず、このような密封中空容器を作成する場
合には、予備成形体から焼成した複数の部品を接合する
ことにより製造されている。
However, since PTFE cannot be injection-molded or the like as described above, it is impossible to integrally mold a sealed hollow container. When such a sealed hollow container is produced, it is fired from a preform. It is manufactured by joining a plurality of components.

【0005】図7は、複数部品を接合して形成した従来
の密封中空容器の一例を示したものである。この密封中
空容器1は、薬液貯蔵部2aを備えた容器本体2と、こ
の容器本体2の開口部を閉塞する蓋体3とからなり、円
筒状に形成されている。なお、符号4は、後にノズル等
が装着される薬液取り出し用の孔または薬液排出用のド
レンバルブが装着される孔を示したものである。
FIG. 7 shows an example of a conventional sealed hollow container formed by joining a plurality of parts. The hermetically sealed hollow container 1 includes a container main body 2 having a chemical solution storage section 2a, and a lid 3 for closing an opening of the container main body 2, and is formed in a cylindrical shape. Reference numeral 4 denotes a hole for taking out a chemical solution to which a nozzle or the like is mounted later, or a hole for mounting a drain valve for discharging a chemical solution.

【0006】ここで、容器本体2および蓋体3は、予備
成形体を焼成することにより製造されているが、これら
の予備成形体を製造するには、例えば、図8に示したよ
うに、金型6内にPTFEの粉末7を充填し、次いで粉
体7を圧縮成形している。その後、得られた予備成形体
は炉内に収容され、PTFEの融点(327℃)以上の
温度、例えば360〜380°Cで焼成されることによ
り容器本体2および蓋体3が形成されている。そして、
これらの焼成品は、後に内部が切削加工され、次いで、
容器本体2と蓋体3とが溶接されて、図7に示したよう
に、ノズルやドレンが装着される前の密封中空容器1が
構成される。また、PTFEは自己融着性がないため、
容器本体2および蓋体3の接合には、PTFEとの融着
性を有するPFAを用いたPFA溶接法により行なわれ
ている。
Here, the container main body 2 and the lid 3 are manufactured by firing the preformed body. To manufacture these preformed bodies, for example, as shown in FIG. A mold 6 is filled with PTFE powder 7 and then the powder 7 is compression molded. Thereafter, the obtained preformed body is housed in a furnace, and fired at a temperature equal to or higher than the melting point of PTFE (327 ° C.), for example, 360 to 380 ° C., to form the container body 2 and the lid 3. . And
These baked products are internally cut later, and then
The container main body 2 and the lid 3 are welded to form the sealed hollow container 1 before the nozzle or the drain is attached, as shown in FIG. Also, since PTFE has no self-fusing property,
The joining of the container body 2 and the lid 3 is performed by a PFA welding method using PFA having a fusion property with PTFE.

【0007】[0007]

【発明が解決しようとする課題】ところで、PFA溶接
により接合された上記の密封中空容器1は、以下のよう
な問題がある。
The above-mentioned sealed hollow container 1 joined by PFA welding has the following problems.

【0008】すなわち、通常PTFE製の密封中空容器
1は、上記したように焼成後、内面が切削加工されるた
め、内面の平滑性は悪くなっているのが一般的である。
したがって、この微細な凹凸面にゴミが溜りやすく、ま
た薬液との接触面積も大きくなるので、パーティクルの
滞留や、クリーン度の維持、洗浄性などの点で問題にな
っていた。
That is, since the inner surface of the hermetically sealed hollow container 1 made of PTFE is cut after firing as described above, the inner surface is generally poor in smoothness.
Therefore, dust easily accumulates on the fine uneven surface, and the contact area with the chemical solution is increased. Therefore, there have been problems in terms of retention of particles, maintenance of cleanness, and cleanability.

【0009】また、密封中空容器1の溶接は外側からし
か行なうことができないため、その溶接部5の強度は、
他の箇所に比べて弱くなっている。したがって、使用に
耐え得る充分な強度を有しておらず、さらに外側溶接の
みを行なった溶接部5を備えた密封中空容器1にあって
は、薬液貯蔵部2aに充填された薬液が内側から溶接部
5の隙間にしみこみ易く、この溶接部5の隙間に薬液が
しみ込んでしまうと、純水で繰り返し洗浄しても、薬液
が残存してしまう傾向にある。すると、他の溶液と入れ
代える場合などに、薬液が持ち越され、この薬液が新た
な薬液と混じり合ってしまうという問題があった。
Further, since the sealed hollow container 1 can be welded only from the outside, the strength of the welded portion 5 is
It is weaker than other parts. Therefore, in the sealed hollow container 1 which does not have sufficient strength to withstand use and further has the welded portion 5 subjected to only the outer welding, the chemical solution filled in the chemical solution storage portion 2a receives the chemical solution from the inside. The chemical solution easily penetrates into the gap between the welded portions 5, and if the chemical solution seeps into the gap between the welded portions 5, the chemical solution tends to remain even after repeated washing with pure water. Then, when replacing with another solution, the chemical solution is carried over, and there is a problem that this chemical solution mixes with a new chemical solution.

【0010】本発明は、このような実情に鑑み、薬液の
持ち越しがなく洗浄性に優れ、高強度で、高純度用薬液
の保存に好適な密封中空容器およびその製造方法を提供
することを目的としている。
SUMMARY OF THE INVENTION In view of such circumstances, an object of the present invention is to provide a sealed hollow container which is excellent in cleaning properties without carrying over a chemical solution, has high strength, and is suitable for storing a chemical solution for high purity, and a method for producing the same. And

【0011】[0011]

【課題を解決するための手段】上記目的を達成するため
の本発明は、耐熱性、耐透過性、耐薬品性およびクリー
ン性に優れたフッ素樹脂から形成した薬液貯蔵用の密封
中空容器であって、前記密封中空容器は、内面を切削加
工することにより薬液貯蔵部を形成した容器本体と、こ
の容器本体の開口部に装着される蓋体とからなるととも
に、前記容器本体および蓋体は、溶融状態から加工でき
ない変性ポリテトラフルオロエチレンから形成され、前
記変性ポリテトラフルオロエチレンは、 式[I]: CF2=CF-O-X・・・・[I] {式[I]中、Xは炭素数1〜6のパーフルオロアルキ
ル基、炭素数4〜9のパーフルオロアルコキシアルキル
基、または式[II]:
SUMMARY OF THE INVENTION In order to achieve the above object, the present invention provides a sealed hollow container for storing a chemical solution formed of a fluororesin having excellent heat resistance, permeability resistance, chemical resistance and cleanliness. The hermetically sealed hollow container includes a container main body in which a chemical solution storage portion is formed by cutting an inner surface, and a lid attached to an opening of the container main body, and the container main body and the lid are It is formed from a modified polytetrafluoroethylene that cannot be processed from a molten state, and the modified polytetrafluoroethylene is represented by the following formula [I]: CF 2 CFCF—O—X (I) Is a perfluoroalkyl group having 1 to 6 carbon atoms, a perfluoroalkoxyalkyl group having 4 to 9 carbon atoms, or a formula [II]:

【0012】[0012]

【化2】 Embedded image

【0013】(式[II]中、nは0または1を示す。)
で表される基を示す。}で表されるパーフルオロビニル
エーテルから誘導される成分単位、およびテトラフルオ
ロエチレンから誘導される成分単位とを含有する共重合
体であって、前記式[I]で表されるパーフルオロビニ
ルエーテルから誘導される成分単位が0.001〜1重
量%の量で含有されている変性ポリテトラフルオロエチ
レンであり、前記容器本体と前記蓋体とは、融着ととも
に再焼成されて一体化されていることを特徴としてい
る。
(In the formula [II], n represents 0 or 1.)
Represents a group represented by A copolymer comprising a component unit derived from a perfluorovinyl ether represented by} and a component unit derived from tetrafluoroethylene, wherein the copolymer is derived from a perfluorovinyl ether represented by the formula [I]. Is a modified polytetrafluoroethylene containing 0.001 to 1% by weight of a component unit, and the container body and the lid are refired together with fusion to be integrated. It is characterized by.

【0014】このような本発明によれば、溶接箇所のな
い密封中空容器を提供することができ、これにより薬液
のしみ込みがなく、純粋性を高めることが可能になっ
た。また、本発明に係る密封中空容器の製造方法は、請
求項1の変性PTFEにより、薬液貯留部を備えた容器
本体およびこの容器本体の開口部に装着される蓋体に対
応する予備成形体をそれぞれ形成するとともに、これら
の予備成形体を焼成し、内面を切削加工して得た成形体
を該成形体の外形寸法より2〜5%大きい寸法に設計さ
れた融着用金型を使用して融着するとともに再焼成処理
を施すことを特徴としている。
According to the present invention, it is possible to provide a hermetically sealed hollow container having no welded portion, thereby preventing the chemical solution from seeping and improving the purity. Further, the method for producing a sealed hollow container according to the present invention is characterized in that the modified PTFE according to claim 1 includes a preformed body corresponding to a container main body having a chemical solution storage part and a lid attached to an opening of the container main body. These preforms are formed and fired, and the formed body obtained by cutting the inner surface of the preformed body is welded using a fusion mold designed to have a size larger than the outer dimension of the formed body by 2 to 5%. It is characterized in that it is fused and subjected to refiring.

【0015】このような方法によれば、変性PTFEの
有する特性により容器本体の切削加工した内面は平滑に
なることが判明した。すなわち、従来のPTFEを原料
とした場合、再焼成されると、金型拘束されない、フリ
ーな表面には、塊状突起物が形成され、さらに前述した
ように切削加工面の表面状態の悪さと相まって、薬液貯
留される容器内表面の状態はさらに悪化する。しかし、
変性PTFEの切削加工面を再焼成すると、顕著な塊状
突起物が生じることはなく、切削加工面の微細な凹凸が
緩和され、表面状態はむしろ改善され、表面平滑化され
ることを見いだした。
According to such a method, it has been found that the cut inner surface of the container body becomes smooth due to the properties of the modified PTFE. That is, when the conventional PTFE is used as a raw material, when refired, a lump is formed on a free surface which is not restrained by a mold, and is combined with the poor surface condition of the cut surface as described above. However, the state of the inner surface of the container in which the chemical is stored is further deteriorated. But,
It has been found that when the cut surface of the modified PTFE is refired, no remarkable massive projections are generated, fine irregularities on the cut surface are alleviated, the surface state is rather improved, and the surface is smoothed.

【0016】これにより、接液側内面を平滑に形成する
ことができ、パーティクルがたまり易い箇所を可及的に
少なくすることができた。また、寸法精度を向上させる
こともできた。したがって、本発明の方法により、液晶
半導体製造あるいは医療等に使用される薬液を貯留する
のに好適な密封中空容器を提供することが可能になっ
た。
As a result, the inner surface on the liquid contact side can be formed smoothly, and the portion where particles easily accumulate can be reduced as much as possible. In addition, the dimensional accuracy could be improved. Therefore, according to the method of the present invention, it has become possible to provide a sealed hollow container suitable for storing a chemical solution used for manufacturing a liquid crystal semiconductor or medical treatment.

【0017】[0017]

【発明の実施の形態】以下、図面を参照しながら本発明
の実施例について説明する。図1は本発明の一実施例に
係る密封中空容器10を示したものである。この密封中
空容器10は、薬液の貯蔵部11aを備えた容器本体1
1と、この容器本体11の開口部11bに装着される蓋
体12とから構成されている。なお、符号13は薬液の
出し入れに使用されるノズルやドレン等が装着される孔
を示したものである。
Embodiments of the present invention will be described below with reference to the drawings. FIG. 1 shows a sealed hollow container 10 according to one embodiment of the present invention. The sealed hollow container 10 includes a container body 1 having a storage section 11a for a chemical solution.
1 and a lid 12 attached to the opening 11b of the container body 11. Reference numeral 13 denotes a hole for mounting a nozzle, a drain, and the like used for taking in and out of the chemical solution.

【0018】この密封中空容器10は、耐熱性、耐薬品
性およびクリーン性に優れた変性PTFE(ポリテトラ
フルオロエチレン)から形成されている。また、この場
合、前記変性ポリテトラフルオロエチレンは、 式[I]: CF2=CF-O-X・・・・[I] {式[I]中、Xは炭素数1〜6のパーフルオロアルキ
ル基、炭素数4〜9のパーフルオロアルコキシアルキル
基、または式[II]:
The sealed hollow container 10 is made of modified PTFE (polytetrafluoroethylene) having excellent heat resistance, chemical resistance and cleanliness. In this case, the modified polytetrafluoroethylene has the following formula [I]: CF 2 CFCF—O—X... [I] In the formula [I], X is a perfluoro group having 1 to 6 carbon atoms. An alkyl group, a perfluoroalkoxyalkyl group having 4 to 9 carbon atoms, or a formula [II]:

【0019】[0019]

【化3】 Embedded image

【0020】(式[II]中、nは0または1を示す。)
で表される基を示す。}で表されるパーフルオロビニル
エーテルから誘導される成分単位、およびテトラフルオ
ロエチレンから誘導される成分単位とを含有する共重合
体であって、前記式[I]で表されるパーフルオロビニ
ルエーテルから誘導される成分単位が0.001〜1重
量%の量で含有されている変性ポリテトラフルオロエチ
レンである。
(In the formula [II], n represents 0 or 1.)
Represents a group represented by A copolymer comprising a component unit derived from a perfluorovinyl ether represented by} and a component unit derived from tetrafluoroethylene, wherein the copolymer is derived from a perfluorovinyl ether represented by the formula [I]. Is a modified polytetrafluoroethylene containing 0.001 to 1% by weight of a component unit.

【0021】変性ポリテトラフルオロエチレンを構成す
るパーフルオロビニルエーテルから誘導される成分単位
としては、例えば、国際公開番号WO93/16126
号に例示されたパーフルオロビニルエーテル由来の各種
から誘導される成分単位が挙げられ、これらのうちで
は、パーフルオロ(プロピルビニルエーテル)単位、パ
ーフルオロ(2-プロポキシプロピルビニルエーテル)
単位が好ましい。
The component units derived from the perfluorovinyl ether constituting the modified polytetrafluoroethylene include, for example, International Publication No. WO93 / 16126.
Component units derived from various types derived from the perfluorovinyl ether exemplified in the above item, among which perfluoro (propyl vinyl ether) unit and perfluoro (2-propoxypropyl vinyl ether)
Units are preferred.

【0022】このようなパーフルオロビニルエーテルか
ら誘導される成分単位は、変性ポリテトラフルオロエチ
レン中に、前述したように通常0.001〜1重量%の
量で、好ましくは0.03〜0.20重量%の量で含有
されていることが望ましい(但し、パーフルオロビニル
エーテルから誘導される成分単位[I]と、テトラフル
オロエチレンから誘導される成分単位との合計を100
重量%とする)。
The component units derived from such a perfluorovinyl ether are contained in the modified polytetrafluoroethylene in an amount of usually 0.001 to 1% by weight, preferably 0.03 to 0.20%, as described above. It is desirable that the content of the component unit [I] derived from perfluorovinyl ether and the component unit derived from tetrafluoroethylene be 100% by weight.
% By weight).

【0023】なお、変性ポリテトラフルオロエチレンに
は、フィラーを適宜配合してもよく、このようなフィラ
ーとしては、例えば、ガラス繊維、グラファイト粉末、
ニッケル粉末などを含んでいてもよい。
A filler may be appropriately added to the modified polytetrafluoroethylene. Examples of such a filler include glass fiber, graphite powder,
It may contain nickel powder and the like.

【0024】このような変性PTFEにより、上記の密
封中空容器10を形成するには、先ず、図2に示したよ
うに、所望とする容器本体11および蓋体12の形状に
近い金型15、16内に原料粉末Fを均一に充填し、通
常300〜500kg/cm2 の圧力で圧縮し、その圧
力を0.5〜10分間保持し、中実構造のブロック状の
予備成形体17、18を得る。得られた予備成形体1
7、18は、それぞれの金型15、16から取り出され
る。そして、取り出された予備成形体17、18は、炉
19内に収容され、ここで最初の焼成が行なわれる。焼
成に際して、炉19では、一定の速さで焼結温度、例え
ば355℃まで上昇させ、その温度で焼結が全体に均一
に完了するまで焼成し、そのまま炉19の温度を一定の
速さで室温まで下げて冷却を完了する。
In order to form the above-mentioned sealed hollow container 10 by such modified PTFE, first, as shown in FIG. 2, a mold 15 having a desired shape of the container body 11 and the lid 12, 16 is uniformly filled with the raw material powder F, and is usually compressed at a pressure of 300 to 500 kg / cm 2 , and the pressure is maintained for 0.5 to 10 minutes to form a block-shaped preform 17, 18 having a solid structure. Get. The obtained preform 1
7 and 18 are taken out from the respective molds 15 and 16. Then, the taken out preforms 17 and 18 are housed in a furnace 19, where the first firing is performed. At the time of sintering, in the furnace 19, the sintering temperature is raised at a constant speed, for example, to 355 ° C., and sintering is performed at that temperature until the sintering is completed uniformly over the whole, and the temperature of the furnace 19 is maintained at a constant speed. Cool down to room temperature to complete.

【0025】こうして、炉19内で最初の焼成がなされ
た成形体17’、18’は、炉19からいったん取り出
され、内面および孔13等が切削加工される。これによ
り、適正な大きさの薬液収容部11aが形成される。一
方、一次焼成がなされた成形体17’、18’を互いに
融着させるための専用金型20が用意され、この金型2
0内にこれら成形体17’、18’が密封中空容器を構
成する姿勢で互いに組み合わされる。そして、この金型
20を再度、炉19内に収容し、この炉19内におい
て、変性PTFEからなる成形体17’、18’が、例
えば以下の条件下で融着されると同時に再焼成される。
Thus, the compacts 17 'and 18' which have been first fired in the furnace 19 are once taken out of the furnace 19, and the inner surface, the holes 13 and the like are cut. As a result, the liquid medicine storage section 11a having an appropriate size is formed. On the other hand, a dedicated mold 20 for fusing the molded bodies 17 ′ and 18 ′ subjected to the primary firing to each other is prepared.
The molded bodies 17 ′ and 18 ′ are combined with each other in a posture that forms a sealed hollow container. Then, the mold 20 is again housed in the furnace 19, in which the molded bodies 17 ′ and 18 ′ made of modified PTFE are fused and refired, for example, under the following conditions. You.

【0026】ここで、融着する場合の条件について説明
する。なお、以下の条件は、外形216mmφ×長さ3
70mmの中空容器および外形216mmφの蓋体を製
造する場合の例である。
Here, the conditions for fusion will be described. In addition, the following conditions are the outer shape 216mmφ x length 3
This is an example in the case of manufacturing a 70 mm hollow container and a lid having an outer shape of 216 mmφ.

【0027】先ず、融着には専用金型20が使用され
る。もし、専用金型20を使用せずに、融着に必要な圧
力を負荷すると、図3に示したように容器本体11’が
座屈、変形してしまい、所望の形状の製品ができない。
従って、少なくとも外側を拘束するための金型が必要と
なる。また、金型20の寸法を製品外形寸法と一致させ
てしまうと、融着時に熱膨張したその増加分の逃げ場が
無くなってしまい、冷却後には、図4に示したように、
容器本体11’が変形してしまうことになる。そこで、
専用金型20の寸法は、製品外形より2〜5%大きく
し、これにより、融着時における変形を防止して適正な
寸法を得ることができる。
First, a dedicated mold 20 is used for fusion. If a pressure necessary for fusion is applied without using the dedicated mold 20, the container body 11 'buckles and deforms as shown in FIG. 3, and a product having a desired shape cannot be obtained.
Therefore, a mold for restraining at least the outside is required. Also, if the dimensions of the mold 20 are made to match the external dimensions of the product, there is no escape area for the increase due to the thermal expansion at the time of fusion, and after cooling, as shown in FIG.
The container body 11 'will be deformed. Therefore,
The dimensions of the exclusive mold 20 are made 2 to 5% larger than the outer shape of the product, so that deformation during fusion can be prevented and proper dimensions can be obtained.

【0028】また、炉19内に専用金型20をセットし
た後、炉19内で融着する場合の条件は、例えば、図5
に示した通りである。すなわち、先ず最初に室温25℃
から一定の速さで上昇させ5時間かけてPTFEの融点
327℃より高い355℃まで加熱し、その状態で5時
間保持するとともに、その後10時間かけて室温(25
℃)にまで冷却する。このときの加圧は融着面積に対し
て50gf/cm2 である。
The conditions for setting the special mold 20 in the furnace 19 and then fusing in the furnace 19 are as shown in FIG.
As shown in FIG. That is, first, room temperature 25 ° C
And heated to 355 ° C., which is higher than the melting point of PTFE of 327 ° C., over a period of 5 hours, and kept at that state for 5 hours.
C). The pressure at this time is 50 gf / cm 2 with respect to the fused area.

【0029】このような条件下で、変性PTFEからな
る一次焼成された容器本体11の成形体17’と一次焼
成された蓋体12の成形体18’とが図1に示したよう
に互いに融着される。
Under these conditions, the molded body 17 'of the primary fired container body 11 made of the modified PTFE and the molded body 18' of the primarily fired lid 12 are mutually fused as shown in FIG. Be worn.

【0030】また、得られた密封中空容器10は、寸法
精度に優れており、所望とする形状にすることができ
た。また、このように製造された変性PTFE製の密封
中空容器10では、融着と同時に再焼成されているの
で、図7に示したように、変性PTFEの表面処理を行
なう前に比べて、表面処理を行なった後は、内方の薬液
の貯蔵部11aの切削加工面の微細な凹凸が緩和され、
平滑性が具備されていた。
The obtained sealed hollow container 10 was excellent in dimensional accuracy and could be formed into a desired shape. Also, in the sealed hollow container 10 made of modified PTFE manufactured in this way, since it is re-fired at the same time as the fusion, as shown in FIG. After performing the processing, the fine irregularities on the cut surface of the storage part 11a of the chemical solution on the inside are alleviated,
Smoothness was provided.

【0031】したがって、容器本体11の内面の表面平
滑性が優れており、薬液が接触しても、その表面が平滑
であるので、薬液成分、塵埃などがその表面に残存する
ことがなく、クリーン性に優れるとともに、洗浄回数が
減り、コストの低減を図ることが可能になった。また、
変性PTFEは、ガス、薬液の耐透過性など耐薬品性に
優れ、しかも不純物の溶出が少ないので、液晶、半導
体、医療分野などにおいて薬液の貯留容器として極めて
適している。
Therefore, the inner surface of the container body 11 is excellent in surface smoothness, and the surface is smooth even when contacted with a chemical solution, so that no chemical components, dust and the like remain on the surface, and the surface is clean. In addition to the excellent performance, the number of times of washing is reduced, and the cost can be reduced. Also,
Modified PTFE has excellent chemical resistance such as resistance to gas and chemical liquid permeation, and has little elution of impurities. Therefore, modified PTFE is extremely suitable as a liquid chemical storage container in liquid crystal, semiconductor, medical fields and the like.

【0032】以上、本発明の一実施例について説明した
が、本発明は上記実施例に何ら限定されない。例えば、
上記実施例では、容器本体11と蓋体12との二部材を
互いに融着させているが、中空容器は2部材以上、例え
ば、3部材から構成することもできる。
Although the embodiment of the present invention has been described above, the present invention is not limited to the above embodiment. For example,
In the above embodiment, the two members, the container body 11 and the lid 12, are fused to each other, but the hollow container may be composed of two or more members, for example, three members.

【0033】[0033]

【発明の効果】本発明によれば、変性PTFEを使用す
ることにより密封中空容器に溶接部が存在しないので、
機械的強度を高めることができた。また、溶接部が存在
しないので、その隙間に薬液がしみ込んでしまうことも
ない。さらに、切削加工された薬液貯蔵部の内面が、再
焼成されることにより、内面平滑性を得ることができた
ため、内面の微細な隙間が少なくなった。したがって、
薬液等が染み込んでしまう箇所を可及的に少なくするこ
とができ、これにより薬液の持ち越しがなくなるととも
に、洗浄性を向上させることができた。
According to the present invention, there is no welded portion in the sealed hollow container by using the modified PTFE,
The mechanical strength could be increased. Further, since there is no welded portion, the chemical solution does not seep into the gap. Furthermore, since the inner surface of the cut chemical solution storage portion was refired, the inner surface smoothness could be obtained, and the number of minute gaps on the inner surface was reduced. Therefore,
The location where the chemical solution or the like permeated could be reduced as much as possible, whereby the carry-over of the chemical solution was eliminated and the cleaning property was improved.

【図面の簡単な説明】[Brief description of the drawings]

【図1】図1は、本発明の一実施例による密封中空容器
の断面図である。
FIG. 1 is a sectional view of a sealed hollow container according to an embodiment of the present invention.

【図2】図2は、本発明による方法を簡略化して示す模
式図である。
FIG. 2 is a schematic diagram showing a simplified method according to the invention.

【図3】図3は、専用金型を用いずに圧力を負荷したと
きの容器本体の状態を示す断面図である。
FIG. 3 is a cross-sectional view showing a state of the container body when a pressure is applied without using a dedicated mold.

【図4】図4は、金型寸法が製品寸法と一致したものを
使用ときの冷却後の容器本体の状態を示す断面図であ
る。
FIG. 4 is a cross-sectional view showing a state of the container body after cooling when using a mold whose dimensions match the product dimensions.

【図5】図5は、本発明による方法で、再焼成するとき
の条件を示すグラフである。
FIG. 5 is a graph showing conditions for refiring in the method according to the present invention.

【図6】図6(A)は再焼成する前の切削加工面の顕微
鏡写真であり、図6(B)は再焼成した後の切削加工面
の顕微鏡写真である。
FIG. 6A is a micrograph of the cut surface before re-firing, and FIG. 6B is a micrograph of the cut surface after re-firing.

【図7】図7は、従来の密封中空容器の断面図である。FIG. 7 is a sectional view of a conventional sealed hollow container.

【図8】図8は、予備成形を説明する断面図である。FIG. 8 is a cross-sectional view illustrating preforming.

【符号の説明】[Explanation of symbols]

10 密封中空容器 11 容器本体 11a 貯蔵部 11b 開口部 12 蓋体 17、18 予備成形体 19 炉 20 専用金型 DESCRIPTION OF SYMBOLS 10 Sealed hollow container 11 Container main body 11a Storage part 11b Opening 12 Lid 17,18 Preformed body 19 Furnace 20 Special mold

フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) (C08F 214/26 216:14) B29K 27:18 B29L 22:00 Fターム(参考) 3E035 AA03 BA04 BC02 CA02 4F208 MA10 4F211 AA17J AG07 AH56 TA01 TC14 TH16 TN01 TN87 TQ01 4J100 AC26P AE38Q AE39Q BA02Q BB07Q BB13Q BB18Q BC58Q CA04 JA58 Continued on the front page (51) Int.Cl. 7 Identification code FI Theme coat II (Reference) (C08F 214/26 216: 14) B29K 27:18 B29L 22:00 F term (Reference) 3E035 AA03 BA04 BC02 CA02 4F208 MA10 4F211 AA17J AG07 AH56 TA01 TC14 TH16 TN01 TN87 TQ01 4J100 AC26P AE38Q AE39Q BA02Q BB07Q BB13Q BB18Q BC58Q CA04 JA58

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 耐熱性、耐透過性、耐薬品性およびクリ
ーン性に優れたフッ素樹脂から形成した薬液貯蔵用の密
封中空容器であって、 前記密封中空容器は、内面を切削加工することにより薬
液貯蔵部を形成した容器本体と、この容器本体の開口部
に装着される蓋体とからなるとともに、 前記容器本体および蓋体は、溶融状態から加工できない
変性ポリテトラフルオロエチレンから形成され、 前記変性ポリテトラフルオロエチレンは、 式[I]: CF2=CF-O-X・・・・[I] {式[I]中、Xは炭素数1〜6のパーフルオロアルキ
ル基、炭素数4〜9のパーフルオロアルコキシアルキル
基、または式[II]: 【化1】 (式[II]中、nは0または1を示す。)で表される基
を示す。}で表されるパーフルオロビニルエーテルから
誘導される成分単位、およびテトラフルオロエチレンか
ら誘導される成分単位とを含有する共重合体であって、 前記式[I]で表されるパーフルオロビニルエーテルか
ら誘導される成分単位が0.001〜1重量%の量で含
有されている変性ポリテトラフルオロエチレンであり、 前記容器本体と前記蓋体とは、融着とともに再焼成され
て一体化されていることを特徴とする密封中空容器。
1. A sealed hollow container for storing a chemical solution formed of a fluororesin having excellent heat resistance, permeability resistance, chemical resistance and cleanliness, wherein the sealed hollow container is obtained by cutting an inner surface. A container body having a chemical solution storage section formed therein, and a lid attached to an opening of the container body, wherein the container body and the lid are formed of modified polytetrafluoroethylene which cannot be processed from a molten state; The modified polytetrafluoroethylene is represented by the formula [I]: CF 2 CFCF—O—X... [I] In the formula [I], X is a perfluoroalkyl group having 1 to 6 carbon atoms, and 4 carbon atoms. Or a perfluoroalkoxyalkyl group represented by the formula [II]: (In the formula [II], n represents 0 or 1.) A copolymer comprising a component unit derived from a perfluorovinyl ether represented by} and a component unit derived from tetrafluoroethylene, wherein the copolymer is derived from a perfluorovinyl ether represented by the formula [I]. Is a modified polytetrafluoroethylene containing 0.001 to 1% by weight of a component unit, wherein the container body and the lid are refired together with fusion to be integrated. A sealed hollow container.
【請求項2】請求項1の変性PTFEにより、薬液貯留
部を備えた容器本体およびこの容器本体の開口部に装着
される蓋体に対応する予備成形体をそれぞれ形成すると
ともに、これらの予備成形体を焼成し、内面を切削加工
して得た成形体を該成形体の外形寸法より2〜5%大き
い寸法に設計された融着用金型を使用して融着するとと
もに再焼成処理を施すことを特徴とする密封中空容器の
製造方法。
2. The modified PTFE of claim 1 forms a preform corresponding to a container body provided with a chemical solution storage portion and a lid attached to an opening of the container body, and preforms these preforms. The molded body obtained by firing the body and cutting the inner surface is fused using a fusion mold designed to have a size larger than the outer dimension of the molded body by 2 to 5%, and subjected to a refiring treatment. A method for producing a hermetically sealed hollow container.
JP10261031A 1998-09-01 1998-09-01 Hermetically sealed hollow container, and its manufacture Pending JP2000140067A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10261031A JP2000140067A (en) 1998-09-01 1998-09-01 Hermetically sealed hollow container, and its manufacture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10261031A JP2000140067A (en) 1998-09-01 1998-09-01 Hermetically sealed hollow container, and its manufacture

Publications (1)

Publication Number Publication Date
JP2000140067A true JP2000140067A (en) 2000-05-23

Family

ID=17356100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10261031A Pending JP2000140067A (en) 1998-09-01 1998-09-01 Hermetically sealed hollow container, and its manufacture

Country Status (1)

Country Link
JP (1) JP2000140067A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009096547A1 (en) * 2008-02-01 2009-08-06 Asahi Glass Company, Limited Ethylene-tetrafluoroethylene copolymer

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009096547A1 (en) * 2008-02-01 2009-08-06 Asahi Glass Company, Limited Ethylene-tetrafluoroethylene copolymer
US8415439B2 (en) 2008-02-01 2013-04-09 Asahi Glass Company, Limited Ethylene-tetrafluoroethylene copolymer
JP5402644B2 (en) * 2008-02-01 2014-01-29 旭硝子株式会社 Ethylene-tetrafluoroethylene copolymer

Similar Documents

Publication Publication Date Title
JP4847632B1 (en) Medical stopper surface-coated skived film, medical stopper using the film, prefilled syringe using the stopper, and method for producing the film
US2400091A (en) Molding process
US4707314A (en) Process for producing polytetrafluoroethylene porous films
WO2019244433A1 (en) Method for manufacturing fired body of fluororesin, fired body of fluororesin, method for manufacturing fluororesin dispersion, method for manufacturing fired body, fluororesin dispersion, and fired body
EP1348683A3 (en) Low temperature, extrudable, high density, reactive materials
US4267237A (en) Molded preformed polytetrafluoroethylene structures
JP7348483B2 (en) Molded product manufacturing method and molded product
JP2000140067A (en) Hermetically sealed hollow container, and its manufacture
JPH0593086A (en) Method for producing porous molded article of polytetrafluoroethylene
JPH06293069A (en) Method for smoothing fluoroplastic molded product and smooth molded product
TW202208189A (en) Three-dimensional formed object
JP2001088217A (en) Method and fusion jig for producing square container made of fluoroplastic resin
EP1160275A1 (en) Crosslinkable elastomer composition, sealing material produced from the composition, and filler for use therein
JP4176190B2 (en) Molding method of resin molding
JP2000240579A (en) Manufacture of chip seal for scroll compressor
JP6612001B1 (en) Fluorine resin fired body production method, fluororesin fired body, fluororesin dispersion production method, fired body production method, fluororesin dispersion, and fired body
JPH07145253A (en) Method for improving water repellency of molded article of polytetrafluoroethylene
JP2000331980A (en) Bubbler and manufacture thereof
JP3056482B1 (en) gasket
JPH11330029A (en) Chemicals treating bath
JP3836621B2 (en) Method for producing glassy carbon pipe
JPS61169231A (en) Manufacture of polytetrafluoroethylene resin sheet
JPH0493232A (en) Manufacture of polytetrafluoroethylene resin molded article
JPH0510444A (en) Manufacture of diaphragm made of fluorocarbon resin
EP4180226A1 (en) Thermoplastic elastomer powders for additive manufacturing and the use thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050830

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080422

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080930